Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eledon Pharmaceuticals (ELDN) Total Non-Current Liabilities (2016 - 2017)

Historic Total Non-Current Liabilities for Eledon Pharmaceuticals (ELDN) over the last 3 years, with Q3 2017 value amounting to $94000.0.

  • Eledon Pharmaceuticals' Total Non-Current Liabilities fell 2166.67% to $94000.0 in Q3 2017 from the same period last year, while for Sep 2017 it was $94000.0, marking a year-over-year decrease of 2166.67%. This contributed to the annual value of $84000.0 for FY2016, which is 454.55% down from last year.
  • Per Eledon Pharmaceuticals' latest filing, its Total Non-Current Liabilities stood at $94000.0 for Q3 2017, which was down 2166.67% from $245000.0 recorded in Q2 2017.
  • In the past 5 years, Eledon Pharmaceuticals' Total Non-Current Liabilities ranged from a high of $6.2 million in Q1 2016 and a low of $48000.0 during Q1 2017
  • Its 3-year average for Total Non-Current Liabilities is $1.7 million, with a median of $138000.0 in 2016.
  • Within the past 5 years, the most significant YoY rise in Eledon Pharmaceuticals' Total Non-Current Liabilities was 5705.13% (2017), while the steepest drop was 9922.29% (2017).
  • Over the past 3 years, Eledon Pharmaceuticals' Total Non-Current Liabilities (Quarter) stood at $88000.0 in 2015, then fell by 4.55% to $84000.0 in 2016, then rose by 11.9% to $94000.0 in 2017.
  • Its Total Non-Current Liabilities was $94000.0 in Q3 2017, compared to $245000.0 in Q2 2017 and $48000.0 in Q1 2017.